CRISPR Therapeutics Newsroom

TD Cowen Maintains CRISPR Therapeutics(CRSP.US) With Sell Rating, Maintains Target Price $30

Moomoo NewsJul 23 07:33 ET

CRISPR Therapeutics Analyst Ratings

BenzingaJun 27 05:35 ET

CRISPR Therapeutics Analyst Ratings

BenzingaJun 17 05:37 ET

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Crispr Therapeutics AG (CRSP) and Tango Therapeutics (TNGX)

TipRanksMay 23 19:05 ET

CRISPR Therapeutics Analyst Ratings

BenzingaMay 23 13:28 ET

Citigroup Maintains Buy on CRISPR Therapeutics, Lowers Price Target to $84

BenzingaMay 23 13:28 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Mersana Therapeutics (MRSN), Insulet (PODD) and Crispr Therapeutics AG (CRSP)

TipRanksMay 14 05:45 ET

Stifel Nicolaus Sticks to Their Hold Rating for Crispr Therapeutics AG (CRSP)

TipRanksMay 12 22:15 ET

CRISPR Therapeutics Analyst Ratings

BenzingaMay 10 12:48 ET

Oppenheimer Adjusts CRISPR Therapeutics Price Target to $95 From $102, Maintains Outperform Rating

MT NewswiresMay 10 10:09 ET

Buy Rating Affirmed for Crispr Therapeutics AG on Strong Pipeline and Financial Health

TipRanksMay 10 01:35 ET

Barclays Maintains Equal-Weight on CRISPR Therapeutics, Lowers Price Target to $67

BenzingaMay 9 10:50 ET

Baird Adjusts Price Target on CRISPR Therapeutics to $52 From $46, Keeps Neutral Rating

MT NewswiresMay 9 10:18 ET

CRISPR Therapeutics Analyst Ratings

BenzingaMay 9 06:42 ET

Crispr Therapeutics AG: A Balanced Hold Rating Amidst Pipeline Progress and Financial Caution

TipRanksMay 9 06:31 ET

Barclays Reaffirms Their Hold Rating on Crispr Therapeutics AG (CRSP)

TipRanksMay 9 03:47 ET

Strong Buy Rating for Crispr Therapeutics AG Amid Innovative Advances and Global Expansion

TipRanksMay 9 01:11 ET

Analysts Are Bullish on These Healthcare Stocks: Alnylam Pharma (ALNY), Crispr Therapeutics AG (CRSP)

TipRanksMay 7 07:46 ET

Buy Rating on Crispr Therapeutics: Anticipated Clinical Catalysts and Undervalued Autoimmune Prospects

TipRanksMay 2 03:25 ET

Buy Rating on Crispr Therapeutics AG Backed by Exa-cel's Precision and Favorable Safety Profile

TipRanksApr 26 02:25 ET